title: High-resolution manometric evaluation of the effects of cisapride on the esophagus during administration of solid and liquid boluses in awake healthy dogs.
abstract: OBJECTIVE To validate the use of high-resolution manometry (HRM) in awake, healthy dogs and compare the effects of bolus type (liquid vs solid) and drug treatment (saline [0.9% NaCl] solution [SS] vs cisapride) on esophageal pressure profiles. ANIMALS 8 healthy dogs. PROCEDURES In a crossover study, each dog received SS (10 mL) IV, and HRM was performed during oral administration of 10 boluses (5 mL each) of water or 10 boluses (5 g each) of canned food. Cisapride (1 mg/kg in 60 mL of SS) was subsequently administered IV to 7 dogs; HRM and bolus administration procedures were repeated. Two to 4 weeks later, HRM was repeated following administration of SS and water and food boluses in 4 dogs. Pressure profile data were obtained for all swallows, and 11 outcome variables were statistically analyzed. RESULTS After SS administration, predicted means for the esophageal contractile integral were 850.4 cm/mm Hg/s for food boluses and 660.3 cm/mm Hg/s for water boluses. Predicted means for esophageal contraction front velocity were 6.2 cm/s for water boluses and 5.6 cm/s for food boluses after SS administration. Predicted means for residual LES pressure were significantly higher following cisapride administration. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that HRM was feasible and repeatable in awake healthy dogs of various breeds and sizes. Stronger esophageal contractions and faster esophageal contraction velocity occurred during solid bolus and liquid bolus swallows, respectively. Lower esophageal sphincter pressure increased significantly following cisapride administration. Esophageal contractions and bolus transit latency should be further evaluated by HRM in clinically dysphagic dogs.
authors.forename: Tarini V
authors.initials: TV
authors.lastname: Ullal
authors.forename: Philip H
authors.initials: PH
authors.lastname: Kass
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Conklin
authors.forename: Peter C
authors.initials: PC
authors.lastname: Belafsky
authors.forename: Stanley L
authors.initials: SL
authors.lastname: Marks
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001947:Breeding; D020117:Cisapride / Q000008:administration & dosage / Q000494:pharmacology*; D018592:Cross-Over Studies; D003679:Deglutition / Q000187:drug effects; D004285:Dogs / Q000502:physiology*; D004947:Esophagus / Q000187:drug effects*; D005260:Female; D005772:Gastrointestinal Transit / Q000187:drug effects*; D008297:Male; D008365:Manometry / Q000662:veterinary; D011312:Pressure; D012016:Reference Values
chemical_list: D000897:Anti-Ulcer Agents; D020117:Cisapride